Morinda citrifolia (Noni) Juice Suppresses A549 Human Lung Cancer Cells via Inhibiting AKT/Nuclear Factor-κB Signaling Pathway
Back to article page
Original Article|Updated:2021-09-01
|
Morinda citrifolia (Noni) Juice Suppresses A549 Human Lung Cancer Cells via Inhibiting AKT/Nuclear Factor-κB Signaling Pathway
Morinda citrifolia (Noni) Juice Suppresses A549 Human Lung Cancer Cells via Inhibiting AKT/Nuclear Factor-κB Signaling Pathway
Chinese Journal of Integrative Medicine2021年27卷第9期 页码:688-695
Affiliations:
1.Laboratory Center, the Third People's Hospital of Huizhou, Affiliated Hospital of Guangzhou Medical University, Huizhou, Guangdong Province (516002), China
2.Clinical Laboratory, the Third People's Hospital of Huizhou, Affiliated Hospital of Guangzhou Medical University, Huizhou, Guangdong Province (516002), China
Ling-di MA, Gui-bin LIN, Lu-bo YANG, 等. Morinda citrifolia (Noni) Juice Suppresses A549 Human Lung Cancer Cells via Inhibiting AKT/Nuclear Factor-κB Signaling Pathway[J]. Chinese Journal of Integrative Medicine, 2021,27(9):688-695.
Ling-di MA, Gui-bin LIN, Lu-bo YANG, et al. Morinda citrifolia (Noni) Juice Suppresses A549 Human Lung Cancer Cells via Inhibiting AKT/Nuclear Factor-κB Signaling Pathway[J]. Chinese Journal of Integrative Medicine, 2021,27(9):688-695.
Ling-di MA, Gui-bin LIN, Lu-bo YANG, 等. Morinda citrifolia (Noni) Juice Suppresses A549 Human Lung Cancer Cells via Inhibiting AKT/Nuclear Factor-κB Signaling Pathway[J]. Chinese Journal of Integrative Medicine, 2021,27(9):688-695. DOI: 10.1007/s11655-020-3421-y.
Ling-di MA, Gui-bin LIN, Lu-bo YANG, et al. Morinda citrifolia (Noni) Juice Suppresses A549 Human Lung Cancer Cells via Inhibiting AKT/Nuclear Factor-κB Signaling Pathway[J]. Chinese Journal of Integrative Medicine, 2021,27(9):688-695. DOI: 10.1007/s11655-020-3421-y.
Morinda citrifolia (Noni) Juice Suppresses A549 Human Lung Cancer Cells via Inhibiting AKT/Nuclear Factor-κB Signaling Pathway
摘要
Abstract
Objective:
2
To study the mechanism of the anti-tumor effect of
Morinda citrifolia
(noni).
Methods:
2
The influences of noni juice on cell proliferation
apoptosis
invasion
migration and the activity of AKT/nuclear factor-κB (NF-κB) signaling pathway in A549 human lung cancer cells were detected by MTT
cell counting kit-8
colony formation
Annexin V/PI double labeling
transwell
scratch test and immunoblotting assay
respectively. A549 cells were inoculated into the right axilla of nude mice
followed by noni juice treatment. The body weight of the nude mice was weighed
and the tumor volume and weight were measured. Cell proliferation and expression of apoptosis-related proteins were measured by immunohistochemistry
and the activity of NF-κB signaling pathway was measured by immunoblotting.
Results:
2
The
in vitro
studies showed that noni juice inhibited the A549 cells proliferation
migration and invasion. Noni juice also promoted cells apoptosis in A549 cells. Immunoblotting assay showed that the phosphorylation level of AKT
p50
and STAT3 proteins was inhibited to different extents after noni juice treatment. The
in vivo
studies showed that noni juice effectively suppressed tumor formation of A549 cells in nude mice. Noni juice treatment inhibited the expression of Ki67
PCNA
and Bcl-2 protein in the tumor; while promoted the expression of caspase-3 protein. Additionally
we also found that noni juice treatment could restrain the activity of AKT/NF-κB signaling pathway in the tumor tissue.
Conclusion:
2
Noni juice inhibited the proliferation of A549 lung cancer cells
induced apoptosis
and inhibited cell invasion and migration via regulating AKT/NF-κB signaling pathway.
关键词
Keywords
Morinda citrifolianoni juiceChinese medicinelung cancer cellAKT/NF-κB signaling pathway
references
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
Spiro SG, Tanner NT, Silvestri GA, Janes SM, Lim E, Vansteenkiste JF, et al. Lung cancer: progress in diagnosis, staging and therapy.Respirology 2010;15:44-50.
Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutationpositive non-small-cell lung cancer (EURTAC): a multicentre, openlabel, randomised phase 3 trial. Lancet Oncol 2012;13:239-246.
Lin Y, Wang X, Jin H. EGFR-TKI resistance in NSCLC patients:mechanisms and strategies. Am J Cancer Res 2014;4:411-435.
Zhou B, Wang D, Sun G, Mei F, Cui Y, Xu H. Effect of miR-21 on apoptosis in lung cancer cell through inhibiting the PI3K/Akt/NF-κB signaling pathway in vitro and in vivo. Cell Physiol Biochem 2018;46:999-1008.
Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006;441:431-436.
Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP, Baldwin As.Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Develop 2008;22:1490-1500.
Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Molecul Cancer 2013;12:86.
Johnson DE, O'keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nature Rev Clin Oncol 2018;15:234-248.
Weng MC, Li MH, Chung JG, Liu YC, Wu JY, Hsu FT, et al.Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo. Biomed Pharmacother 2019;116:109032.
Song J, Feng L, Zhong R, Xia Z, Zhang L, Cui L, et al. Icariside Ⅱinhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway. Mol Carcinogen 2017;56:36-48.
Wang MY, West BJ, Jensen CJ, Nowicki D, Su C, Palu AK, et al.Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol Sin 2002;23:1127-1141.
Nualsanit T, Rojanapanthu P, Gritsanapan W, Lee SH, Lawson D, Baek SJ. Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells. J Nutr Biochem 2012;23:915-923.
Sharma K, Pachauri SD, Khandelwal K, Ahmad H, Arya A, Biala P, et al. Anticancer effects of extracts from the fruit of Morinda Citrifolia(Noni) in breast cancer cell lines. Drug Res 2016;66:141-147.
West BJ, White LD, Jensen CJ, Palu AK. A double-blind clinical safety study of noni fruit juice. Pacific health Dialog 2009;15:21-32.
Issell BF, Gotay CC, Pagano I, Franke AA. Using quality of life measures in a phase Ⅰ clinical trial of noni in patients with advanced cancer to select a phase Ⅱ dose. J Diet Supplem 2009;6:347-359.
Palu AK, Kim AH, West BJ, Deng S, Jensen J, White L. The effects of Morinda citrifolia L. (noni) on the immune system: its molecular mechanisms of action. J Ethnopharm 2008;115:502-506.
Wang MY, Lutfiyya MN, Weidenbacher-Hoper V, Anderson G, Su CX, West BJ. Antioxidant activity of noni juice in heavy smokers.Chem Central J 2009;3:13.
Gupta RK, Banerjee A, Pathak S, Sharma C, Singh N. Induction of mitochondrial-mediated apoptosis by Morinda citrifolia (Noni) in human cervical cancer cells. Asian Pacific J Cancer Prev 2013;14:237-242.
Tașkin EI, Akgün-Dar K, Kapucu A, Osanç E, Doǧruman H, Eraltan H, et al. Apoptosis-inducing effects of Morinda citrifolia L.and doxorubicin on the Ehrlich ascites tumor in Balb-c mice. Cell Biochem Funct 2009;27:542-546.
Wang My, Peng L, Lutfiyya Mn, Henley E, Weidenbacher-Hoper V, Anderson G. Morinda citrifolia (noni) reduces cancer risk in current smokers by decreasing aromatic DNA adducts. Nutr Cancer 2009;61:634-639.
Yang L, Zhou Y, Li Y, Zhou J, Wu Y, Cui Y, et al. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. Cancer Lett 2015;357:520-526.
Xu TP, Shen H, Liu LX, Shu YQ. Plumbagin from Plumbago Zeylanica L induces apoptosis in human non-small cell lung cancer cell lines through NF-κB inactivation. Asian Pacific J Cancer Pre 2013;14:2325-2331.
Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E. PI3K/AKT signaling pathway and cancer: an updated review. Ann Med 2014;46:372-383.
Yang Y, Luo J, Zhai X, Fu Z, Tang Z, Liu L, et al. Prognostic value of phospho-Akt in patients with non-small cell lung carcinoma: a meta-analysis. Int J Cancer 2014;135:1417-1424.
Ahmmed B, Khan MN, Nisar MA, Kampo S, Zheng Q, Li Y, et al.Tunicamycin enhances the suppressive effects of cisplatin on lung cancer growth through PTX3 glycosylation via AKT/NF-κB signaling pathway. Int J Oncol 2019;54:431-442.
Riihimaki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J, et al. Metastatic sites and survival in lung cancer. Lung cancer 2014;86:78-84.
Villeneuve PJ, Sundaresan RS. Surgical management of colorectal lung metastasis. Clin Colon Rect Surg 2009;22:233-241.
Caldarella A, Crocetti E, Comin CE, Janni A, Pegna AL, Paci E.Gender differences in non-small cell lung cancer: a population-based study. Eur J Surg Oncol 2007;33:763-768.
Rempe RG, Hartz AMS, Bauer B. Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers. J Cerebr Blood Flow Metab 2016;36:1481-1507.
Tsai JR, Liu PL, Chen YH, Chou SH, Cheng YJ, Hwang JJ, et al. Curcumin inhibits non-small cell lung cancer cells metastasis through the adiponectin/NF-κb/MMPs signaling pathway. PLoS One 2015;10:e0144462.
Merchant N, Nagaraju GP, Rajitha B, Lammata S, Jella KK, Buchwald ZS, et al. Matrix metalloproteinases: their functional role in lung cancer.Carcinogenesis 2017;38:766-780.
Shih YW, Chen PS, Wu CH, Jeng YF, Wang CJ. Alpha-chaconinereduced metastasis involves a PI3K/Akt signaling pathway with downregulation of NF-kappaB in human lung adenocarcinoma A549 cells. J Agricult Food Chem 2007;55:11035-11043.
Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
Immunomodulatory Function of Pien Tze Huang in T Cell-Mediated Anti-tumor Activity against B16-F10, MC38 and Hep1-6 Tumor Models
Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway
Immunoregulatory and Anti-cancer Activities of Combination Treatment of Novel Four-Herb Formula and Doxorubicin in 4T1-Breast Cancer Bearing Mice
TRAIL and Celastrol Combinational Treatment Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells via Targeting Wnt/β-Catenin Signaling Pathway
相关作者
暂无数据
相关机构
Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine
State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Science, Xiamen University
Fujian Pien Tze Huang Enterprise Key Laboratory of Natural Medicine Research and Development
Department of General Surgery, First People's Hospital of Hangzhou Lin'an District
Institute of Chinese Medicine, The Chinese University of Hong Kong